Compare OESX & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OESX | LTRN |
|---|---|---|
| Founded | 1996 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Building Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 47.4M | 46.8M |
| IPO Year | 2007 | 2020 |
| Metric | OESX | LTRN |
|---|---|---|
| Price | $20.77 | $2.12 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $17.50 | N/A |
| AVG Volume (30 Days) | 88.5K | ★ 89.1K |
| Earning Date | 02-05-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 18.65 |
| EPS | ★ 0.47 | N/A |
| Revenue | ★ $86,306,000.00 | N/A |
| Revenue This Year | $7.94 | N/A |
| Revenue Next Year | $13.89 | N/A |
| P/E Ratio | $42.34 | ★ N/A |
| Revenue Growth | ★ 8.26 | N/A |
| 52 Week Low | $6.78 | $1.11 |
| 52 Week High | $20.80 | $4.70 |
| Indicator | OESX | LTRN |
|---|---|---|
| Relative Strength Index (RSI) | 75.82 | 27.19 |
| Support Level | $8.98 | $1.98 |
| Resistance Level | N/A | $2.41 |
| Average True Range (ATR) | 1.96 | 0.22 |
| MACD | 0.14 | -0.03 |
| Stochastic Oscillator | 94.15 | 1.23 |
Orion Energy Systems Inc provide light emitting diode (LED) lighting systems, wireless Internet of Things (IoT) enabled control solutions, commercial and industrial electric vehicle charging infrastructure solutions and lighting and electrical maintenance services. It help its customers achieve their sustainability, energy savings and carbon footprint reduction goals through technology and exceptional service. It sell its products and services into many vertical markets within the broader commercial and industrial market segment. Primary verticals include box retail, manufacturing, warehousing/logistics, federal and municipal government, healthcare and schools. It has three segments Lighting, Maintenance, and EV segment. It generates majority of revenue from Lighting segment.
Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers.